It has been well-documented that high expression of CD44 predicts poor prognosis of various tumors including breast, brain, colon, pancreatic, and gastric tumors, indicating that CD44 may be a valuable prognostic marker and therapeutic target for cancers (7). Here, CD44 is linked to gastric neoplasm.